Active Biotech AB (publ) (Nasdaq Stockholm) carries out a rights issue of approximately SEK 55 million. Vinge advises Active Biotech. Vinge’s team primarily consists of Erik Sjöman, Christian Lindhé, Ludvig Frithiof and Astrid Karlsson.